We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.17B
AUM Growth
-$939M
Cap. Flow
-$328M
Cap. Flow %
-6.34%
Top 10 Hldgs %
49.51%
Holding
202
New
57
Increased
36
Reduced
26
Closed
61

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$121M
2
PTCT icon
PTC Therapeutics
PTCT
+$81.6M
3
VTRS icon
Viatris
VTRS
+$76.4M
4
TGT icon
Target
TGT
+$69.6M
5
FIVE icon
Five Below
FIVE
+$60.3M

Sector Composition

Rank Sector Weight
1 Healthcare 45.3%
2 Consumer Staples 9.22%
3 Consumer Discretionary 6.86%
4 Technology 3.5%
5 Communication Services 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GROY.WS
126
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$354K 0.01%
448,000
NXGLW icon
127
NexGel Inc Warrant
NXGLW
$245K ﹤0.01%
+550,000
New +$280K
NLSPW
128
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$190K ﹤0.01%
500,000
BEATW icon
129
Heartbeam Inc Warrant
BEATW
$185K ﹤0.01%
+500,000
New +$266K
APCXW
130
DELISTED
AppTech Payments Corp Warrant
APCXW
$179K ﹤0.01%
+715,000
New +$235K
SWAGW icon
131
Stran & Company Warrant
SWAGW
$91.1K
$179K ﹤0.01%
545,000
KTTAW icon
132
Pasithea Therapeutics Warrants
KTTAW
$21.4K
$170K ﹤0.01%
1,000,000
AREBW
133
DELISTED
American Rebel Holdings Warrants
AREBW
$169K ﹤0.01%
+4,819
New +$183K
CINGW icon
134
Cingulate Inc Warrants
CINGW
$35.4K
$164K ﹤0.01%
410,000
GROMW
135
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$145K ﹤0.01%
24,100
CYRN
136
DELISTED
CYREN Ltd.
CYRN
$139K ﹤0.01%
+27,615
New +$150K
LCFYW icon
137
Locafy Ltd Warrant
LCFYW
$134K ﹤0.01%
+12,121
New +$148K
PETVW
138
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$66K ﹤0.01%
200,000
DRMAW icon
139
Dermata Therapeutics Warrant
DRMAW
$14.1K
$52K ﹤0.01%
325,000
SQLLW
140
DELISTED
SeqLL Inc. Warrant
SQLLW
$20K ﹤0.01%
50,000
UPH.WS
141
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$2K ﹤0.01%
+10,000
New +$3.08K
ACCO icon
142
Acco Brands
ACCO
$407M
-500,000
Closed -$4.13M
AEO icon
143
American Eagle Outfitters
AEO
$2.97B
-408,878
Closed -$10.4M
ASO icon
144
Academy Sports + Outdoors
ASO
$2.94B
-1,510,086
Closed -$66.3M
BAX icon
145
Baxter International
BAX
$14B
-224,000
Closed -$19.2M
BLUE
146
DELISTED
bluebird bio
BLUE
-117,400
Closed -$23.5M
BTBT icon
147
Bit Digital
BTBT
$475M
-4,215,852
Closed -$25.6M
SLAI
148
DELISTED
SOLAI Ltd ADS
SLAI
-12,571
Closed -$5.4M
CFLT
149
DELISTED
Confluent
CFLT
-124,000
Closed -$9.45M
CRM icon
150
Salesforce
CRM
$153B
-85,000
Closed -$21.6M

Similar funds

Armistice Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Armistice Capital held 202 positions worth $5.17B, down 15% from $6.11B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital withdrew a net $328M in Q1 2022, closing 61 positions and reducing 26 holdings. Its most notable exit was Academy Sports + Outdoors, an estimated $66.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in Home Depot worth $105M.

  • Armistice Capital's largest Q1 2022 buy was Home Depot: 349,897 shares worth $105M.
  • Armistice Capital added most to PTC Therapeutics in Q1 2022, an estimated $81.6M increase.
  • Armistice Capital's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $62.3M.
  • Armistice Capital fully exited Academy Sports + Outdoors in Q1 2022, selling an estimated $66.3M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.17B portfolio in Q1 2022.
  • Armistice Capital opened 57 new positions and closed 61 in Q1 2022.
  • Armistice Capital's portfolio value fell 15% quarter-over-quarter to $5.17B.

Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.